<DOC>
	<DOC>NCT01476111</DOC>
	<brief_summary>This study will examine specific biomarkers in primary invasive breast cancer and explore their correlation with patient outcome following standard neoadjuvant treatment.</brief_summary>
	<brief_title>Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>The patient has 18 years of age or older at the time of consent. The patient has provided pretreatment tumor samples for WT1 expression screening and gene expression profiling in the context of the NCT01220128 study. The patient has a histologically or cytologically confirmed primary invasive breast cancer. The patient has provided written informed consent before any new information or new material is provided to the Sponsor. The patient is planned to receive, is receiving or has received standard and/or investigational therapy for breast cancer. The patient is planned to receive, is receiving or has received standard and/or investigational therapy for breast cancer.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>tumor antigens</keyword>
	<keyword>observational</keyword>
	<keyword>breast cancer</keyword>
	<keyword>biomarkers</keyword>
	<keyword>Neoadjuvant</keyword>
</DOC>